Eversept Partners LP Invests $10.99 Million in Teleflex Incorporated (NYSE:TFX)

Eversept Partners LP acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 61,736 shares of the medical technology company's stock, valued at approximately $10,988,000. Teleflex comprises approximately 1.0% of Eversept Partners LP's portfolio, making the stock its 21st largest holding. Eversept Partners LP owned 0.13% of Teleflex as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Massar Capital Management LP acquired a new stake in Teleflex during the 4th quarter worth approximately $331,000. J. Safra Sarasin Holding AG increased its position in shares of Teleflex by 18.5% in the fourth quarter. J. Safra Sarasin Holding AG now owns 8,393 shares of the medical technology company's stock worth $1,494,000 after acquiring an additional 1,312 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Teleflex by 198.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 4,449 shares of the medical technology company's stock valued at $792,000 after acquiring an additional 2,958 shares during the period. Speece Thorson Capital Group Inc. lifted its holdings in shares of Teleflex by 51.9% during the 4th quarter. Speece Thorson Capital Group Inc. now owns 72,778 shares of the medical technology company's stock valued at $12,953,000 after acquiring an additional 24,874 shares in the last quarter. Finally, Natixis boosted its position in Teleflex by 1,990.8% during the 4th quarter. Natixis now owns 65,651 shares of the medical technology company's stock worth $11,685,000 after purchasing an additional 62,511 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

TFX has been the subject of several analyst reports. Morgan Stanley decreased their target price on Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. Royal Bank of Canada cut Teleflex from an "outperform" rating to a "sector perform" rating and decreased their price target for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Wells Fargo & Company dropped their price objective on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Truist Financial decreased their target price on shares of Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Finally, StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $169.63.

Teleflex Stock Up 1.8 %

Teleflex stock traded up $2.42 during midday trading on Thursday, hitting $135.44. The stock had a trading volume of 691,766 shares, compared to its average volume of 629,399. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The business has a fifty day moving average price of $140.85 and a 200 day moving average price of $175.02. Teleflex Incorporated has a 12 month low of $124.66 and a 12 month high of $249.91. The stock has a market cap of $6.28 billion, a P/E ratio of 26.93, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's dividend payout ratio is currently 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.